Key Points •Alzheimer's disease involves not just genetics, but also “epigenetic” changes that control how genes function. •Serotonergic psychedelics like psilocybin and LSD are being studied for their ability to promote neuroplasticity and reduce neuroinflammation. •Emerging research suggests psychedelics can modulate epigenetic mechanisms, potentially correcting...
Key Takeaways •A new presidential executive order directs the U.S. government to speed up research and access to psychedelic treatments for serious mental illness. •The FDA will issue priority review vouchers to fast-track the approval process for breakthrough psychedelic therapies. •New pathways are opening for...
Key Points •Psychological stress can accelerate cancer growth by influencing the nervous system and tumor environment. •Psychedelic compounds like psilocybin and ketamine show promise in rapidly reducing cancer-related depression and anxiety. •These substances may interrupt the communication between stress signals and tumor progression. •By promoting...
Key Points •New research shows that different doses of psilocybin produce distinct effects on the brain and behavior. •Moderate doses appear to be more effective for reducing anxiety-like behaviors. •Higher doses seem necessary to produce antidepressant-like effects and promote significant neuroplasticity.•The effects are tied to...